AngioWaveNet vs CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00

AngioWaveNet emphasizes minimal disruption to existing workflows, vendor-agnostic compatibility, and quick configuration, suggesting a low barrier to adoption. It requires minimal training and is designed to be intuitive, allowing clinicians to review images side-by-side without delaying procedures.

CARTOu2122 3 EP Navigation System Software V8.0 offers a comprehensive suite of AI-powered features for 3D cardiac mapping, navigation, and enhanced signal analysis, directly improving diagnosis and treatment of complex heart rhythm disorders. Its AI algorithms for automated anatomy creation and advanced signal analysis provide a deeper and more multifaceted clinical impact on procedural success.

AngioWaveNet offers transparent pricing models, including annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs, with custom packages available. This transparency and flexibility allow for clearer budget planning and easier assessment of value. In contrast, CARTOu2122 3 EP Navigation System Software V8.0 requires direct consultation for pricing, lacking public transparency.

Both tools are FDA-cleared and address HIPAA compliance, demonstrating strong regulatory and security readiness. AngioWaveNet's vendor-agnostic compatibility and flexible deployment options (cloud or on-premise) offer broad adaptability, while CARTOu2122 3 EP Navigation System Software V8.0 provides robust on-premise deployment with optional cloud storage and field-upgradeable software for minimal downtime.

CARTOu2122 3 EP Navigation System Software V8.0 integrates multiple AI/ML components for real-time 3D cardiac mapping, automated anatomy creation, advanced signal analysis, and catheter navigation, representing a higher degree of innovation in complex interventional cardiology. Features like the CARTOSOUNDu2122 FAM Module, which uses an FDA-cleared AI algorithm for automated 3D left atrial anatomy creation, showcase advanced AI application.

AngioWave Imaging provides full onboarding support, including installation, staff training, and access to ongoing updates and clinical resources, with FDA guidance-compliant documentation. Biosense Webster offers a comprehensive 'Therapy Advancement Program' with resources, training expertise centers, and clinical account specialists for real-time support, alongside field-upgradeable software and on-screen troubleshooting. Both demonstrate robust support structures essential for complex medical devices.